333 related articles for article (PubMed ID: 19400744)
1. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance.
Weinstein MP; Klugman KP; Jones RN
Clin Infect Dis; 2009 Jun; 48(11):1596-600. PubMed ID: 19400744
[TBL] [Abstract][Full Text] [Related]
2. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae--United States, 2006-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(50):1353-5. PubMed ID: 19092758
[TBL] [Abstract][Full Text] [Related]
3. Effect of new breakpoints proposed by Clinical and Laboratory Standards Institute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hospital.
Doğan O; Gülmez D; Hasçelik G
Microb Drug Resist; 2010 Mar; 16(1):39-41. PubMed ID: 19916790
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18.
Su LH; Wu TL; Kuo AJ; Chia JH; Chiu CH
J Antimicrob Chemother; 2009 Aug; 64(2):336-42. PubMed ID: 19520718
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
6. New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008).
Imöhl M; Reinert RR; van der Linden M
Int J Antimicrob Agents; 2009 Sep; 34(3):271-3. PubMed ID: 19419844
[TBL] [Abstract][Full Text] [Related]
7. Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(7):152-4. PubMed ID: 14985653
[TBL] [Abstract][Full Text] [Related]
8. Impact of the revised penicillin susceptibility breakpoints for Streptococcus pneumoniae on antimicrobial resistance rates of meningeal and non-meningeal pneumococcal strains.
Al-Waili BR; Al-Thawadi S; Hajjar SA
Ann Saudi Med; 2013; 33(2):111-5. PubMed ID: 23562996
[TBL] [Abstract][Full Text] [Related]
9. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
[TBL] [Abstract][Full Text] [Related]
10. Comparison of susceptibility test methods to detect penicillin susceptibility in Streptococcus pneumoniae isolates.
Mohd Nasir MD; Parasakthi N
Malays J Pathol; 2004 Jun; 26(1):29-33. PubMed ID: 16190104
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activities of carbapenem antimicrobial agents against 264 penicillin-resistant Streptococcus pneumoniae isolates from Korea.
Choi SH; Park SJ; Jun JB; Lee SR; Jeon MH; Kwon HH; Kim SC; Kim MN; Jeong JY; Woo JH; Kim YS
Diagn Microbiol Infect Dis; 2007 May; 58(1):141-3. PubMed ID: 17368803
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
13. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 May; 51(18):392-4. PubMed ID: 12018795
[TBL] [Abstract][Full Text] [Related]
14. Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time.
Mera RM; Miller LA; Amrine-Madsen H; Sahm DF
Microb Drug Resist; 2011 Mar; 17(1):47-52. PubMed ID: 21117969
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
[No Abstract] [Full Text] [Related]
16. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
Soriano F
Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745
[No Abstract] [Full Text] [Related]
17. Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013).
Imöhl M; Reinert RR; Tulkens PM; van der Linden M
Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):2035-40. PubMed ID: 24930041
[TBL] [Abstract][Full Text] [Related]
18. Both penicillin and amoxycillin should be tested in antimicrobial surveillance for Streptococcus pneumoniae.
Garau J
Clin Microbiol Infect; 2005 May; 11(5):422-3. PubMed ID: 15819875
[No Abstract] [Full Text] [Related]
19. Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003.
Johnson AP; Lamagni TL; Wale M; Cavendish S; Bishop L; Alhaddad N; Warner M; Livermore DM; Duckworth G; George RC
Int J Antimicrob Agents; 2005 Jun; 25(6):539-41. PubMed ID: 15890501
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
